GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » Earnings per Share (Diluted)

C21 Investments (C21 Investments) Earnings per Share (Diluted) : $-0.03 (TTM As of Oct. 2023)


View and export this data going back to . Start your Free Trial

What is C21 Investments Earnings per Share (Diluted)?

C21 Investments's Earnings per Share (Diluted) for the three months ended in Oct. 2023 was $-0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.03.

C21 Investments's EPS (Basic) for the three months ended in Oct. 2023 was $-0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.03.

C21 Investments's EPS without NRI for the three months ended in Oct. 2023 was $-0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Oct. 2023 was $-0.02.

During the past 12 months, C21 Investments's average EPS without NRIGrowth Rate was -209.50% per year.

During the past 13 years, C21 Investments's highest 3-Year average EPS without NRI Growth Rate was 47.40% per year. The lowest was -120.30% per year. And the median was 7.10% per year.


C21 Investments Earnings per Share (Diluted) Historical Data

The historical data trend for C21 Investments's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Earnings per Share (Diluted) Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.76 -0.43 -0.07 0.08 -

C21 Investments Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.02 - - -

Competitive Comparison of C21 Investments's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's PE Ratio distribution charts can be found below:

* The bar in red indicates where C21 Investments's PE Ratio falls into.



C21 Investments Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

C21 Investments's Earnings Per Share (Diluted) for the fiscal year that ended in Jan. 2023 is calculated as

Diluted Earnings Per Share (A: Jan. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(0.293-0)/122.881
=0.00

C21 Investments's Earnings Per Share (Diluted) for the quarter that ended in Oct. 2023 is calculated as

Diluted Earnings Per Share (Q: Oct. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.376-0)/122.881
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


C21 Investments  (OTCPK:CXXIF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


C21 Investments Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of C21 Investments's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments (C21 Investments) Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 280, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company. It cultivates, processes, manufactures, and distributes cannabis and hemp-derived consumer products. C21's focus is to expand where the company can wholly own indoor or outdoor cultivation operations, extraction facilities, bakeries, branded products, and retail dispensaries with a large distribution network.

C21 Investments (C21 Investments) Headlines

From GuruFocus

C21 Investments Announces Q1 Results

By PRNewswire PRNewswire 08-13-2020

Year-End Letter to Shareholders

By PRNewswire PRNewswire 02-10-2020

C21 Addresses Market Conditions to Shareholders

By PRNewswire PRNewswire 03-13-2020

C21's Nevada Dispensaries Achieve Record Retail Revenue for Q2

By PRNewswire PRNewswire 08-04-2020

C21 Investments Announces Q2 Results

By PRNewswire PRNewswire 09-24-2020